Higher levels of both p-CaMK-II and Nav1.5 were observed in the TAC-only compared to both sham-operated and TAC + empagliflozin groups (P < 0.001 in both cases; P < 0.001 and 0.01, respectively; Fig. 2b,c). The gene discussed is SCN5A; the disease is persistent truncus arteriosus.